Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient's cells.
Investing.com - Freedom Capital Markets raised its price target on Butterfly Network stock (NYSE:BFLY) to $5.50 from $5.00 while maintaining a Buy rating on the shares. The firm cited embedded revenue ...
Nokia is positioning Network as Code as a monetization engine that converts complex telecom infrastructure into standardized, secure APIs developers can embed into enterprise and IoT applications. The ...